Results
1
High return on equity, past performance and sound balance sheet.
1 companies
Pharma Mar
Market Cap: €1.4b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€83.25
7D
5.7%
1Y
-6.1%